In patients with Acquired Immune Deficiency Syndrome (AIDS) having an active SARS-CoV-2 infection, CD4+ T-cell lymphopenia is associated with poorer outcomes [51,52], even when nAbs are produced. Here, CD4 is linked to lymphopenia.